Table 3.
% of cell proliferationa,b |
||||
---|---|---|---|---|
HeLac |
HCT116/chr3d |
|||
compd | 0.5 μM | 1 μM | 0.5 μM | 1 μM |
24 | 47±0.5 | 56±1.2 | 60±0.8 | 60±3.9 |
27 | 53±0.1 | 60±0.1 | 57±0.9 | 62±1.9 |
28 | 41±1.1 | 47±0.4 | 59±0.2 | 66±3.5 |
29 | 52±0.4 | 45±1.6 | 51±4.6 | 51±1.6 |
36 | 57±1.4 | 43±0.3 | 63±1.0 | 54±1.0 |
39 | 55±0.7 | 54±0.3 | 57±3.4 | 55±1.2 |
41 | 52±0.7 | 51±0.2 | 69±6.7 | 69±0.3 |
Data are expressed as % mean values ± SD; control cells are considered as 100% (MTT method).
Treatments were performed for 24 h at the indicated concentrations.
HeLa cervical cancer cells.
HCT116/chr3 human colon cancer cells.